Evidence map›Paper›PMID 24530854›Full record

ReviewCurrent opinion in structural biology2014

The spliceosome: disorder and dynamics defined.

Weijun Chen, Melissa J Moore

Abstract readReview
In one paragraph

Review in Current opinion in structural biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed.

  1. Article
  2. Article
  3. Gene regulation through exon junction complex modularity.Nature structural & molecular biology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Weijun ChenHoward Hughes Medical Institute, Department of Biochemistry and Molecular Pharmacology, RNA and Neuro Therapeutics Institutes, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Melissa J MooreHoward Hughes Medical Institute, Department of Biochemistry and Molecular Pharmacology, RNA and Neuro Therapeutics Institutes, University of Massachusetts Medical School, Worcester, MA 01655, USA. Electronic address: melissa.moore@umassmed.edu.

Funding

The second step of pre-mRNA splicingR01GM053007 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MOORE, MELISSA J. · 1995 to 2018
$5.6M
Howard Hughes Medical InstituteNIGMS NIH HHS R01 GM053007NIGMS NIH HHS R01-GM53307
6 · The paper itself

Abstract

Among the many macromolecular machines involved in eukaryotic gene expression, the spliceosome remains one of the most challenging for structural biologists. Defining features of this highly complex apparatus are its excessive number of individual parts, many of which have been evolutionarily selected for regions of structural disorder, and the remarkable compositional and conformation dynamics it must undertake to complete each round of splicing. Here we review recent advances in our understanding of spliceosome structural dynamics stemming from bioinformatics, deep sequencing, high throughput methods for determining protein-protein, protein-RNA and RNA-RNA interaction dynamics, single molecule microscopy and more traditional structural analyses. Together, these tools are rapidly changing our structural appreciation of this remarkably dynamic machine.

Indexed as

RNA SplicingAnimalsComputational BiologyHumansModels, MolecularProtein Interaction MapsProtein Processing, Post-TranslationalRibonucleoproteinsRNASpliceosomesRibonucleoproteinsRNA

Identifiers

PMID24530854
PMCPMC3987960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.